Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Keer Jin"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 180, Iss , Pp 117483- (2024)
The progression of high-grade squamous intraepithelial lesion (HSIL) to invasive cervical cancer (ICC) is a complex process involving persistent human papillomavirus (HPV) infection and changes in signal transduction regulation, energy and material m
Externí odkaz:
https://doaj.org/article/77cd1566ba33495f8800ed21a23510d6
Autor:
Jia Zhu, Rui Zhang, Dongxiang Yang, Jibin Li, Xiaofei Yan, Keer Jin, Wenya Li, Xin Liu, Jianfeng Zhao, Wen Shang, Tao Yu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 1, Pp 113-128 (2018)
Background/Aims: Doxorubicin (DOX) is a widely used chemotherapeutic agent for colorectal cancer (CRC). However, the acquirement of DOX resistance limits its clinical application for cancer therapy. Mounting evidence has suggested that aberrantly exp
Externí odkaz:
https://doaj.org/article/52a43b590c7841159928366860298550
Autor:
Bo Lian, Dongxiang Yang, Yanlong Liu, Gang Shi, Jibin Li, Xiaofei Yan, Keer Jin, Xin Liu, Jianfeng Zhao, Wen Shang, Rui Zhang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 49, Iss 6, Pp 2151-2162 (2018)
Background/Aims: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an ideal anti-tumor drug because it exhibits selective cytotoxicity against cancer cells. However, certain cancer cells are resistant to TRAIL, and the potential mech
Externí odkaz:
https://doaj.org/article/61e2b12c65474749a3dc005b60af2f8a
Publikováno v:
Oncology Reports. 47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24798c3f392c66847c0600eef08cf96e
https://doi.org/10.3892/or.2022.8274
https://doi.org/10.3892/or.2022.8274
Autor:
Rui Zhang, Jibin Li, Xiaofei Yan, Keer Jin, Wenya Li, Xin Liu, Jianfeng Zhao, Wen Shang, Yefu Liu
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Retracted on authors' request due to detected data flaws. Reference: Rui Zhang, Jibin Li, Xiaofei Yan, Keer Jin, Wenya Li, Xin Liu, Jianfeng Zhao, Wen Shang, Yefu Liu. Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::935c53705befdeaedab00b0e8720e70b
https://pubmed.ncbi.nlm.nih.gov/34355706
https://pubmed.ncbi.nlm.nih.gov/34355706
Autor:
Rui Zhang, Jibin Li, Yefu Liu, Jianfeng Zhao, Wenya Li, Wen Shang, Xiaofei Yan, Xin Liu, Keer Jin
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Recently, long noncoding RNAs (lncRNAs) have received wide attention in the area of tumor progression. Dysregulation of lncRNAs has been shown to participated in colon cancer, a known malignant tumor. This study aimed to identify the way l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dfd8485f84eeb3b32094ad1d048d404
http://europepmc.org/articles/PMC6286632
http://europepmc.org/articles/PMC6286632
Autor:
Xin Liu, Jianfeng Zhao, Keer Jin, Jibin Li, Xiaofei Yan, Wen Shang, Wenya Li, Rui Zhang, Gang Shi
Publikováno v:
Advances in Clinical and Experimental Medicine. 28:479-487
Background Chemotherapy for colorectal cancer remains an unsatisfactory method of treatment and requires the development of more advanced drug delivery systems (DDSs). Among inorganic materials, silica nanoparticles (SLNs) have been considered a suit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::342c018aeba15022dd42c94ebef9fc75
https://doi.org/10.17219/acem/79561
https://doi.org/10.17219/acem/79561
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Limited efficacy of immune checkpoint blockades was observed in clinical trials in colorectal (CRC) patients, especially in the microsatellite-stable patients. Interleukin-6 (IL-6) is critical in modeling immune responses in cancers. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2170bb4c312761962a85177e35f16f
http://europepmc.org/articles/PMC6097097
http://europepmc.org/articles/PMC6097097
Autor:
Xiaofei Yan, Yanlong Liu, Dongxiang Yang, Rui Zhang, Xin Liu, Jibin Li, Wen Shang, Jianfeng Zhao, Keer Jin, Bo Lian, Gang Shi
Publikováno v:
Cellular Physiology and Biochemistry, Vol 49, Iss 6, Pp 2151-2162 (2018)
Background/Aims: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an ideal anti-tumor drug because it exhibits selective cytotoxicity against cancer cells. However, certain cancer cells are resistant to TRAIL, and the potential mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87185ef42343b9870df5798a28cf7835
https://doi.org/10.1159/000493818
https://doi.org/10.1159/000493818
Autor:
Rui Zhang, Tao Yu, Xin Liu, Wen Shang, Jianfeng Zhao, Xiaofei Yan, Keer Jin, Wenya Li, Dongxiang Yang, Jia Zhu, Jibin Li
Publikováno v:
Cellular Physiology and Biochemistry, Vol 51, Iss 1, Pp 113-128 (2018)
Background/Aims: Doxorubicin (DOX) is a widely used chemotherapeutic agent for colorectal cancer (CRC). However, the acquirement of DOX resistance limits its clinical application for cancer therapy. Mounting evidence has suggested that aberrantly exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::866d788aa92ac6fdb0a5215b995b4ade
https://pubmed.ncbi.nlm.nih.gov/34735062
https://pubmed.ncbi.nlm.nih.gov/34735062